SOLIGENIX, INC. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-12-09

Reporting Person: Guarino Jonathan L. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Stock Option (Right to Buy)	$0.78	A	50000	Acquired	2031-12-08	COMMON STOCK (50000)	Direct

Footnotes

F1: The stock option vested immediately as to 12,500 shares and vests as to the remainder at a rate of 3,125 of the shares on each three (3) month anniversary of December 9, 2021.